<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03601520</url>
  </required_header>
  <id_info>
    <org_study_id>IRCCS-SSc-2018</org_study_id>
    <nct_id>NCT03601520</nct_id>
  </id_info>
  <brief_title>Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis</brief_title>
  <acronym>DL-SSc</acronym>
  <official_title>Mechanisms of Pulmonary Diffusion Limitation in Systemic Sclerosis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study was designed to test the hypothesis that, irrespective of the degree of interstiaI
      lung disease and/or pulmonary arterial hypertension, the combined measurement of lung
      diffusing capacity for nitric oxide and carbon monoxide, might be useful to provide a
      mechanistic interpretation of changes of diffusion subcomponents in systemic sclerosis (SSc).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In systemic sclerosis (SSc) the impairment of lung function is generally inferred from
      measurements of forced vital capacity (FVC) and standard lung diffusing capacity for carbon
      monoxide (DLCO). However, FVC measurement does not provide an accurate estimate of lung
      restriction and DLCO does not allow separate the alveolar membrane (DMCO) from erythrocyte
      (DeCO) diffusive conductance for CO. Previous studies have shown that DMCO and DeCO may
      change irrespective of overt intersitial lung disease (ILD) and/or pulmonary arterial
      hypertension (PAH). These changes may be consistent with a limitation of alveolar-capillary
      erythrocyte recruitment which impairs DM.This study was designed to test the hypothesis that,
      irrespective of the degree of ILD and/or PAH, combined DLNO-DLCO measurement might be useful
      to provide a mechanistic interpretation of DM and De changes in SSc.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 1, 2014</start_date>
  <completion_date type="Actual">November 15, 2017</completion_date>
  <primary_completion_date type="Actual">October 31, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung diffusing capacity for nitric oxide</measure>
    <time_frame>2 hours</time_frame>
    <description>Alveolar-capillary gas exchange</description>
  </primary_outcome>
  <enrollment type="Actual">100</enrollment>
  <condition>Diffusion Limitation of Pulmonary Gas Exchange in Systemic Sclerosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        SSc patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients fulfilling the 2013 American College of Rheumatology/European League Against
             Rheumatism criteria for a definite diagnosis of SSc with a total score â‰¥9

        Exclusion Criteria:

          -  unstable subjects and/or who have suffered from respiratory exacerbations in the
             previous 4-wk
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <reference>
    <citation>Barisione G, Bacigalupo A, Brusasco C, Scanarotti C, Penco S, Bassi AM, Lamparelli T, Garlaschi A, Pellegrino R, Brusasco V. Mechanisms for reduced pulmonary diffusing capacity in haematopoietic stem-cell transplantation recipients. Respir Physiol Neurobiol. 2014 Apr 1;194:54-61. doi: 10.1016/j.resp.2014.01.018. Epub 2014 Feb 1.</citation>
    <PMID>24495442</PMID>
  </reference>
  <reference>
    <citation>Barisione G, Brusasco C, Garlaschi A, Baroffio M, Brusasco V. Lung diffusing capacity for nitric oxide as a marker of fibrotic changes in idiopathic interstitial pneumonias. J Appl Physiol (1985). 2016 May 1;120(9):1029-38. doi: 10.1152/japplphysiol.00964.2015. Epub 2016 Feb 18.</citation>
    <PMID>26893034</PMID>
  </reference>
  <verification_date>July 2018</verification_date>
  <study_first_submitted>July 17, 2018</study_first_submitted>
  <study_first_submitted_qc>July 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>July 25, 2018</last_update_submitted>
  <last_update_submitted_qc>July 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">July 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy</investigator_affiliation>
    <investigator_full_name>Giovanni Barisione</investigator_full_name>
    <investigator_title>MD, Pulmonary Function Lab Director</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Scleroderma, Systemic</mesh_term>
    <mesh_term>Scleroderma, Diffuse</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

